Akero Therapeutics, Inc.
USD54.65
+0.00 (+0.00%)
CEO
Andrew Cheng
IPO Date
2019-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$54.52
Prev. Close
$54.65
Day Low
$54.52
Day High
$54.65
52W Low
$21.34
52W High
$58.40
Market Cap
$4.50B
Volume
11.61M
| -8.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -34.3% | -31.4% | 0.03 | 18.61 | -19.1 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -59.6% | -51.5% | 0.01 | 7.70 | -7.3 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -30.6% | -29.0% | 0.01 | 20.70 | -10.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -34.0% | -31.7% | 0.00 | 14.73 | -7.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 163.7% | -105.9% | 0.00 | 32.93 | -4.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 100.0% | -693.6% | 0.00 | 2.87 | -114.6 |
| -15.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -6.5% | -6.1% | 0.03 | 16.80 | -11.3 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -9.3% | -8.5% | 0.05 | 19.38 | -7.0 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -9.8% | -8.9% | 0.05 | 17.25 | -6.9 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -7.0% | -6.5% | 0.05 | 24.89 | -7.2 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -6.3% | -5.8% | 0.04 | 30.12 | -6.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -10.3% | -9.5% | 0.05 | 29.27 | -5.9 |
| 30 Sept 2023 | Q3 | 0.0% | 0.0% | -6.8% | -6.2% | 0.04 | 20.25 | -17.7 |
| 30 Jun 2023 | Q2 | 0.0% | 0.0% | -5.0% | -4.7% | 0.04 | 29.78 | -19.5 |